Victoza is designed to be used with diet and exercise
Insights from multi-omics integration in complex disease primary tissues
Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats
Larr S, Tran N, Fan C, Hamadeh H, Champigneulles J, Azzouzi R, Cussenot O, Mangin P, Olivier JL
Several health conditions are already known to increase the risk of NAION, including: Type 2 diabetes High blood pressure Heart disease Prior heart attack Sleep apnea Obesity Many patients who take GLP-1 medications may already have one or more of these risk factors, which is one reason researchers continue to investigate the potential relationship between semaglutide and NAION
She is knowledgeable & passionate about her work